Navigation Links
Astellas Named Elite Winner for Employee Engagement and Commitment in 'Chicago's 101 Best and Brightest Companies to Work For' Competition
Date:8/11/2009

DEERFIELD, Ill., Aug. 11 /PRNewswire/ -- In a ceremony recognizing "Chicago's 101 Best and Brightest Companies to Work For," Astellas Pharma US, Inc. won an Elite award for employee engagement and commitment by the National Association for Business Resources (NABR). Astellas scored high in all 10 categories and was specifically recognized for the high level of employees' engagement and pride in the company.

"At Astellas, we understand that investment in our employees is vital to reaching our corporate goals and it is even more critical in these tough economic times," said Seigo Kashii, president and CEO of Astellas. "Being selected as 'Chicago's 101 Best and Brightest Companies to Work For' further validates our commitment to our employees and being a recognized employer of choice in the Chicago area and the pharmaceutical industry."

"We are honored to recognize the efforts of this year's 101 'Best and Brightest' companies. These companies have created impressive organizational value and business results through their policies and best practices in human resource management. This award has become a powerful recruitment tool in the drive to attract and retain exceptional employees," said Jennifer Kluge, NABR president.

The NABR's annual list of "Best and Brightest Companies" compiles the results of an independent research firm that evaluates each company's entry in the following categories: communication, community initiatives, compensation and benefits, diversity and multiculturalism, employee education and development, employee engagement and commitment, recognition and retention, small business, recruitment and selection, and work-life balance. The judges look for unique and creative thought processes with support from senior management and policy makers.

About Astellas

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the US, Astellas markets products in the areas of Immunology, Urology, Anti-Infectives, Cardiovascular and Dermatology. For more information about Astellas Pharma US, Inc., please visit our website at www.us.astellas.com.

About The National Association for Business Resources

The National Association for Business Resources (NABR) advocates and represents small and medium-sized businesses throughout the United States. NABR specializes in providing businesses the benefits, programs, services, and assistance required to operating as efficiently and successfully as possible. Best practice solutions are available to members in the areas of human resources, healthcare, legal, transaction, compliance, marketing, and office services. For more information about NABR and its offerings, please visit www.nationalbiz.org or call 1-866-321-1822.


'/>"/>
SOURCE Astellas Pharma US, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardiome And Astellas Announce Regulatory Update
2. FDA Approves Additional Indication for Astellas MYCAMINE(R)
3. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
4. Astellas Launches Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
5. Astellas Announces New Vice President of Marketing
6. Astellas Hires New Vice President of Compliance
7. Astellas Adds CNS Therapy Area Leader to Global R&D Team
8. Astellas Names Head of Global R&D Operations
9. NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)
10. AUA Foundation names the 2009 Astellas Rising Stars in Urology award winners
11. Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... Forgive You”: a fine examination of how God handles sin, including how to let ... Stephen Miller, who, for over ten long years has been waiting to release this powerful ... Tobago, he has been serving the Lord for over twenty years, and he has been ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Journey to Christmas:” a beautiful and enchanting ... of published author, Kimberly Cordoves, a mother of three in Oklahoma City, and a devoted ... idea of writing a book has been in the back of my mind for years, ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “God's Miracle ... Against All Odds” is the creation of published author, Keith C. A. Tucker, son ... the Christian Fellowship World Outreach pastured by Reverend Mark Hardy , “While sitting up ...
(Date:1/19/2017)... ... January 19, 2017 , ... Next week after January 20th, ... by Congressional political games that circumvent health needs of over 30 million. Many interviews ... human anxieties and needs government public servants were suppose to prioritize. Interviews provided below. ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... This month, ... announced that the name of their drug rehab center in Delray Beach, Florida has ... recognize that not only stars such as Philip Seymour Hoffman and Chris Farley are ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... 2017  Ethicon Endo-Surgery, Inc. announced today ... Inc., a privately held medical device company ... used in operating rooms worldwide. The acquisition ... energy devices with Megadyne,s innovative portfolio of ... in Ethicon,s goal to deliver the most ...
(Date:1/20/2017)... Fla. , Jan. 20, 2017 Wells Specialty ... at 3796 Howell Branch Rd in Winter Park, ... Winter Park . Operations have been consolidated into ... Pharmacy is also pleased to announce that Chad Tomlinson ... President of the Company effective immediately. Mr. Tomlinson is a ...
(Date:1/19/2017)... YORK , Jan. 19, 2017 ... USD 233.7 billion by 2025, according to a ... market is anticipated to be predominantly driven by ... resulting into the large-scale production of new and ... the influx of drugs at an unprecedented rate ...
Breaking Medicine Technology: